ECG Devices Market Forecasts to 2030 – Global Analysis By Product (Resting ECG Systems, Stress ECG Systems, Holter Monitors, Event Monitors, Mobile Cardiac Telemetry (MCT) Devices, Smart ECG Monitors, Implantable Loop Recorders (ILRs), Cardiopulmonary Str

ECG Devices Market Forecasts to 2030 – Global Analysis By Product (Resting ECG Systems, Stress ECG Systems, Holter Monitors, Event Monitors, Mobile Cardiac Telemetry (MCT) Devices, Smart ECG Monitors, Implantable Loop Recorders (ILRs), Cardiopulmonary Stress Testing Systems and Other Products), Technology, End User and By Geography

According to Stratistics MRC, the Global ECG Devices Market is accounted for $6.71 billion in 2023 and is expected to reach $12.51 billion by 2030 growing at a CAGR of 9.3% during the forecast period. Electrocardiogram (ECG) devices are medical instruments used to record the electrical activity of the heart over a specific period of time. They are crucial tools for diagnosing and monitoring various heart conditions. ECG devices measure and record the electrical impulses that trigger each heartbeat. ECG devices come in various forms, including portable and handheld models and can serve both diagnostic and monitoring purposes. ECG devices typically have a user-friendly interface and are designed to be comfortable for patients during the procedure.

According to the Centers for Disease Control and Prevention, cardiovascular diseases are the most common health problems faced by people across the globe, with high mortality rate accounting for 696,962 deaths in 2020 in the United States.

Market Dynamics

Driver

Growing prevalence of cardiovascular diseases

ECG devices play a crucial role in diagnosing and monitoring various cardiac conditions. As the number of individuals with cardiovascular diseases rises, there is a greater need for accurate and reliable diagnostic tools to assess heart health. Many cardiovascular diseases are chronic and require ongoing monitoring. ECG data provides valuable information for healthcare providers to make informed decisions about treatment options, medication adjustments, and interventions for patients with cardiovascular conditions. Further, its tailoring treatment plans and preventive healthcare initiatives are fuelling the market growth.

Restraint

Stringent regulations

Stringent regulatory requirements, particularly in regions like the United States and the European Union, can be a significant challenge for companies in the ECG devices market. Changes in regulatory standards or unexpected compliance issues can lead to delays in product approvals or market withdrawals. Therefore, the high costs and complex processes associated with obtaining regulatory approval may limit the number of players in the market.

Opportunity

Rising remote patient monitoring

RPM allows patients to be monitored from the comfort of their homes. Patients no longer need to make frequent trips to healthcare facilities for ECG readings. Continuous monitoring through RPM enables early detection of irregularities in heart activity. By reducing the need for hospital or clinic visits, RPM can lead to cost savings for both patients and healthcare providers. Further, healthcare providers can focus their attention on patients who require immediate attention. In addition, factors such as telemedicine integration, data-driven care plans and reduced readmission rates are propelling the market growth.

Threat

Competing imaging modalities

In certain clinical scenarios, healthcare providers may prefer more comprehensive imaging modalities like echocardiography or cardiac MRI. These modalities can provide a more detailed and multifaceted view of cardiac structure and function compared to a standard ECG. Also, some imaging modalities require specialized training to perform and interpret. The improved diagnostic capabilities of competing imaging modalities are hampering the market demand.

Covid-19 Impact

The COVID-19 pandemic had a significant impact on the ECG devices market. With the shift towards telemedicine and remote patient monitoring during the pandemic, there was a surge in demand for ECG devices that could be used for remote monitoring of patient’s cardiac health at home. Some healthcare facilities faced budget constraints and resource limitations during the pandemic, which led to delays in purchasing and installing new ECG devices. As healthcare systems recovered from the initial impact of the pandemic, there was a renewed focus on cardiac care, and ECG devices continued to be an essential tool in managing patients with cardiovascular conditions.

The smart ECG monitors segment is expected to be the largest during the forecast period

The smart ECG monitors segment is estimated to have a lucrative growth, due to its digital and connectivity features that enhances the monitoring, analysis, and management of cardiac health. Smart ECG monitors enables real-time data transmission and remote monitoring. They often come with companion mobile apps that can display ECG readings, store historical data, and provide insights into cardiac health. Its long battery life, AI-powered analysis, portability and wearability are thereby boosting the segment demand.

The wireless ECG devices segment is expected to have the highest CAGR during the forecast period

The wireless ECG devices segment is anticipated to witness the highest CAGR growth during the forecast period. Patients can wear wireless ECG monitors comfortably without being restricted by wires. This allows for greater freedom of movement and can lead to improved patient compliance with monitoring protocols. Without physical wires, there's a lower risk of infection associated with the use of wireless ECG devices, making them suitable for long-term wear. Overall, wireless ECG devices offer significant advantages in terms of patient comfort, mobility, and remote monitoring capabilities.

Region with largest share

Asia Pacific is projected to hold the largest market share during the forecast period. The Asia Pacific region is one of the fastest-growing markets for ECG devices. The region is experiencing a rising burden of cardiovascular diseases, driven by factors such as urbanization, sedentary lifestyles, dietary changes, and an aging population. This trend fuels the demand for ECG devices for diagnosis and monitoring. Also, factors such as a large and aging population, increasing prevalence of cardiovascular diseases, and improving healthcare infrastructure contribute to this growth.

Region with highest CAGR

Europe is projected to have the highest CAGR over the forecast period. The ECG devices market in Europe is one of the largest globally, driven by the region's advanced healthcare infrastructure and high prevalence of cardiovascular diseases. Europe is a hub for medical technology innovation. European countries have been investing heavily in digital health infrastructure, and ECG devices were increasingly integrated with electronic health record systems. Europe placed a strong emphasis on patient-centered care which is boosting the market growth.

Key players in the market

Some of the key players profiled in the ECG Devices Market include Medtronic PLC, Aerotel Medical Systems Ltd, QT Medical, AliveCor Inc., Nihon Kohden Corporation, BPL Medical Technologies, Dozee, Bittium, MediBioSense Ltd, CardioComm Solutions Inc., iRhythm Technologies Inc., GE Healthcare, Hill-Rom Holdings, Inc., Koninklijke Philips N.V., Spacelabs Healthcare (OSI Systems, Inc.), Fukuda Denshi Co., Ltd and SCHILLER AG.

Key Developments

In November 2023, Amcor announced the development of the lightest 900-ml Polyethylene Terephthalate (PET) bottle for edible oil in Brazil. The custom-designed bottle for agribusiness and food producer Bunge in São Paulo is 22 percent lighter than other bottles while offering great sustainability benefits.

Products Covered
• Resting ECG Systems
• Stress ECG Systems
• Holter Monitors
• Event Monitors
• Mobile Cardiac Telemetry (MCT) Devices
• Smart ECG Monitors
• Implantable Loop Recorders (ILRs)
• Cardiopulmonary Stress Testing Systems
• Other Products

Technologies Covered
• Digital ECG Devices
• Analog ECG Devices
• Portable ECG Devices
• Wireless ECG Devices
• Leadless ECG Devices
• Smartphone-Based ECG Devices
• Signal Processing ECG Devices
• Telemedicine & Remote Monitoring ECG Devices
• Continuous ECG Monitoring Systems
• Mobile Cardiac Telemetry (MCT) Devices
• Cardiovascular Information Systems (CVIS)

End Users Covered
• Hospital
• Specialized Clinics
• Diagnostic Centers & Laboratories
• Nursing Homes & Long-Term Care Facilities
• Home Healthcare Settings
• Ambulatory Surgical Centers (ASCs)
• Other End Users

Regions Covered
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements